drugset / Trial / NCT05024253

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

NCT05024253

Phase 3 Completed 48 enrolled Children's Cancer Hospital Egypt 57357
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to investigate whether previously reported benefit of Tranexamic acid in pediatric orthopedic surgeries could be recapitulated in bone tumor surgeries or not through a double blinded randomized controlled trial done in children cancer hospital 57357.

Timeline

Start
2021-08-02
Primary completion
2024-02-01
Completion
2024-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 5 mg/kg